PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) EXPRESSION OF MEGAKARYOCYTOPOIESIS IN NORMAL HUMAN BONE-MARROW AND REACTIVE LESIONS WITH SPECIAL EMPHASIS ON HIV-MYELOPATHY
J. Thiele et al., PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) EXPRESSION OF MEGAKARYOCYTOPOIESIS IN NORMAL HUMAN BONE-MARROW AND REACTIVE LESIONS WITH SPECIAL EMPHASIS ON HIV-MYELOPATHY, Pathology research and practice, 190(1), 1994, pp. 42-50
A morphometric analysis was performed on bone marrow trephine biopsies
using sequential double-immunostaining, to evaluate endoreduplicative
activity of megakaryocytopoiesis. A total of 104 marrow specimens wer
e studied with employment of monoclonal antibodies PC10 (anti-prolifer
ating cell nuclear antigen - PCNA) and Y2/51-CD61 (anti-platelet glyco
protein IIIa). In addition to the control group patients included non-
specific inflammatory changes, HIV-myelopathy with normal or decreased
platelet counts, idiopathic thrombocytopenic purpura (ITP), and final
ly reactive thrombocytosis (TH). To exclude an undue overexpression of
PCNA, in a comparative pilot study we also applied MIB1 (Ki-67 antige
n) on normal bone marrow specimens. In accordance with the various mod
alities of cell-cycle marker expression, no significantly different fi
ndings were disclosed. PCNA-labelling index was relatively low, rangin
g from 0.8 to 1.7% of the total megakaryocytopoiesis (promegakaryoblas
ts to mature platelet-shedding megakaryocytes). A significant relation
ship between megakaryocyte size and PCNA-expression was determinable.
This implies that some of the cases with a prevalence of small megakar
yocytes, like ITP, have the tendency to show a higher proportion of po
sitively-stained cells. Moreover, this feature confirms a hypothesis p
ostulating a decrease in the time for DNA-synthesis (S-phase) and a re
lative prolongation of the G1/G2-phases of the cell-cycle at higher pl
oidy levels (large-sized megakaryocytes). On the other hand, it may be
speculated that some of the hyperpolyploid giant megakaryocytes may h
ave reached their endstage of endoreduplication and enter into G0-phas
e. In comparison with the control group and the other entities under s
tudy, a significant reduction of PCNA-reactivity was recognizable in H
IV-myelopathy accompanied by thrombocytopenia. Our findings are in kee
ping with cell culture studies assuming that, opposed to ITP and TH, i
n AIDS different kinetic properties of the megakaryocytic lineage have
to be encountered. In this context, it may not entirely be ruled out
that viral infection has an inhibitory effect on the stability of mRNA
for PCNA and therefore could cause an undue reduction of PCNA-immunos
taining.